US 10584115
Substituted pyridine and pyrazine BMI-1 inhibitors
granted A61KA61K31/497A61K31/4985
Quick answer
US patent 10584115 (Substituted pyridine and pyrazine BMI-1 inhibitors) held by PTC THERAPEUTICS, INC. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/497, A61K31/4985, A61K31/519, A61K31/69